Stonehage Fleming Financial Services Holdings Ltd Has $163.14 Million Stock Holdings in Stryker Co. (NYSE:SYK)

Stonehage Fleming Financial Services Holdings Ltd cut its stake in shares of Stryker Co. (NYSE:SYK) by 4.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 453,104 shares of the medical technology company’s stock after selling 20,366 shares during the period. Stryker comprises approximately 4.6% of Stonehage Fleming Financial Services Holdings Ltd’s holdings, making the stock its 10th largest position. Stonehage Fleming Financial Services Holdings Ltd owned approximately 0.12% of Stryker worth $163,140,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. AQR Capital Management LLC grew its position in shares of Stryker by 9.7% during the 2nd quarter. AQR Capital Management LLC now owns 125,333 shares of the medical technology company’s stock valued at $42,485,000 after acquiring an additional 11,075 shares during the period. Scientech Research LLC raised its stake in shares of Stryker by 46.3% in the second quarter. Scientech Research LLC now owns 1,527 shares of the medical technology company’s stock worth $520,000 after buying an additional 483 shares during the period. Driehaus Capital Management LLC lifted its position in shares of Stryker by 73.8% during the 2nd quarter. Driehaus Capital Management LLC now owns 1,107 shares of the medical technology company’s stock valued at $377,000 after buying an additional 470 shares in the last quarter. Ascent Group LLC increased its holdings in Stryker by 4.4% in the 2nd quarter. Ascent Group LLC now owns 3,790 shares of the medical technology company’s stock worth $1,290,000 after acquiring an additional 159 shares in the last quarter. Finally, Aviso Wealth Management bought a new stake in Stryker during the 2nd quarter worth approximately $203,000. 77.09% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on SYK shares. Royal Bank of Canada reiterated an “outperform” rating and set a $425.00 target price on shares of Stryker in a research report on Tuesday, January 7th. Morgan Stanley raised shares of Stryker from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $370.00 to $445.00 in a report on Monday, December 2nd. Canaccord Genuity Group boosted their target price on shares of Stryker from $360.00 to $400.00 and gave the stock a “buy” rating in a report on Wednesday, October 30th. Evercore ISI upped their target price on shares of Stryker from $380.00 to $384.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, BTIG Research lifted their price target on shares of Stryker from $383.00 to $394.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Five analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $405.80.

Insider Activity

In other news, CEO Kevin Lobo sold 57,313 shares of the stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $368.70, for a total value of $21,131,303.10. Following the sale, the chief executive officer now owns 100,027 shares in the company, valued at $36,879,954.90. This represents a 36.43 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 5.90% of the company’s stock.

Stryker Stock Up 0.1 %

Shares of NYSE SYK opened at $394.08 on Monday. The stock has a market capitalization of $150.23 billion, a PE ratio of 42.24, a price-to-earnings-growth ratio of 2.68 and a beta of 0.95. The company has a current ratio of 1.91, a quick ratio of 1.22 and a debt-to-equity ratio of 0.66. Stryker Co. has a 12-month low of $307.23 and a 12-month high of $398.20. The stock’s fifty day simple moving average is $376.11 and its two-hundred day simple moving average is $360.98.

Stryker (NYSE:SYK) last posted its earnings results on Tuesday, October 29th. The medical technology company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.77 by $0.10. The company had revenue of $5.49 billion during the quarter, compared to analysts’ expectations of $5.37 billion. Stryker had a net margin of 16.34% and a return on equity of 23.07%. Stryker’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.46 earnings per share. As a group, analysts expect that Stryker Co. will post 12.06 EPS for the current fiscal year.

Stryker Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.84 per share. This is an increase from Stryker’s previous quarterly dividend of $0.80. This represents a $3.36 annualized dividend and a dividend yield of 0.85%. The ex-dividend date is Tuesday, December 31st. Stryker’s payout ratio is presently 36.01%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.